Thermo Fisher Scientific Inc.
TMO
$459.30
$6.701.48%
NYSE
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.36% | 3.91% | 3.22% | 2.04% | 0.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.36% | 3.91% | 3.22% | 2.05% | 0.96% |
| Cost of Revenue | 6.28% | 4.49% | 2.35% | 1.35% | -0.53% |
| Gross Profit | 4.06% | 3.09% | 4.49% | 3.06% | 3.13% |
| SG&A Expenses | 1.26% | -0.78% | -0.52% | -0.28% | 0.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -546.67% | -550.00% | 2,900.00% | 2,900.00% | 2,900.00% |
| Total Operating Expenses | 4.31% | 2.57% | 1.84% | 1.26% | 0.10% |
| Operating Income | 10.05% | 10.02% | 9.68% | 5.66% | 4.95% |
| Income Before Tax | 5.68% | 3.86% | 5.26% | 3.51% | 7.32% |
| Income Tax Expenses | 10.59% | -16.87% | -15.13% | -26.72% | -9.06% |
| Earnings from Continuing Operations | 5.32% | 6.01% | 7.40% | 6.42% | 8.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -350.00% | -325.00% | -135.71% | -100.00% | -110.26% |
| Net Income | 5.11% | 5.81% | 7.07% | 5.84% | 7.97% |
| EBIT | 10.05% | 10.02% | 9.68% | 5.66% | 4.95% |
| EBITDA | 5.74% | 4.12% | 2.92% | -0.08% | -0.33% |
| EPS Basic | 6.54% | 7.09% | 8.26% | 7.03% | 9.19% |
| Normalized Basic EPS | 10.52% | 9.93% | 11.03% | 6.86% | 5.96% |
| EPS Diluted | 6.75% | 7.39% | 8.51% | 7.24% | 9.36% |
| Normalized Diluted EPS | 10.73% | 10.21% | 11.31% | 7.00% | 6.09% |
| Average Basic Shares Outstanding | -1.31% | -1.18% | -1.11% | -1.11% | -1.10% |
| Average Diluted Shares Outstanding | -1.50% | -1.43% | -1.36% | -1.23% | -1.23% |
| Dividend Per Share | 10.00% | 10.26% | 10.53% | 10.81% | 11.11% |
| Payout Ratio | 0.03% | 0.03% | 0.02% | 0.04% | 0.02% |